euro adhoc: DocCheck AG / other / DocCheck® AG's growth rate and sales forecast continue to increase in the 3rd quarter

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

06.11.2006

In the 3rd quarter of 2006 DocCheck AG, Cologne, (ISIN DE0005471007
// Symbol 547100) has achieved sales totalling 3.3 million euro. This
corresponds to a growth rate of 33 per cent when compared to the 3rd
quarter of 2005 (2.5 million euro). Earnings before interest and
taxes (EBIT) improved during this period and increased from 0.14
million euro to 0.2 million euro. In the first nine months, sales
increased by 19 per cent rising from 8 million euro to 9.4 million
euro and earnings before taxes grew by 140 per cent from 0.26 million
euro to 0.62 million euro. This means that by the end of the 3rd
quarter, the operating result for the whole of the financial year
2005 has already been exceeded (0.5 million euro). Profit per share
amounts to 10 cent in the first nine months (7 cent for the same
period in the previous year). Both divisions increased their sales.
The DocCheck® division had a 12 per cent increase in sales, rising
from 4.1 million euro to 4.6 million euro when compared to the same
period in the previous year, as it benefited both from organic growth
and for the first time, from consolidation of the new DocCheckShop
site in Leipzig in the 3rd quarter. The antwerpes + partner division
continues to record an increase in new business. Sales increased by
29 per cent when compared to the same period in the previous year,
rising from 3.8 million euro to 4.9 million euro. DocCheck AG is
increasing its sales forecast for the whole of the financial year
2006 from 12.3 million euro to between 12.8 and 13 million euro. When
compared to the previous year's sales totalling 11.2 million euro,
this represents an increase in sales of between 14 per cent and 16
per cent.

end of announcement euro adhoc 06.11.2006 20:00:00
--------------------------------------------------------------------------------

ots Originaltext: DocCheck AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:
Tanja Mumme
+49 (0)221 92053 139
tanja.mumme@doccheck.com

Branche: Computing & Information Technology
ISIN: DE0005471007
WKN: 547100
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Frankfurter Wertpapierbörse / regulated dealing/prime
standard
Börse Berlin-Bremen / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Bayerische Börse / free trade